SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?

The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the drug is much cheaper in Pakistan and China due to government interventions.
|
|||||||||
💡 newsR Knowledge: Other News Mentions
|
![]()
“I Could Call Bukele, But Won’t”: Trump Doubles Down On Abrego García's Deportation To El Salvador
Credit: Oneindia Duration: 03:25Published
|
![]()
China Fumes as U.S Ally Australia Sends Warship to South China Sea| South China Sea Tensions Explode
Credit: Oneindia Duration: 03:38Published
|
![]()
Trump Brags About Tariff Success in China: 'Cargo Ships Turning Back', Says Tariffs Hammering China
Credit: Oneindia Duration: 02:01Published
|
Related news from verified sources
Apple tempted by India! In shift away from China, 70-80 million iPhones to be made in India soon amid Trump tariff tensionsApple is significantly increasing iPhone production in India, aiming for 70-80 million units by late 2026, potentially making India the primary supplier to the...IndiaTimes |
Trump’s tariff blitz on China may have an unexpected winner: IndiaAmidst the trade tensions between the US and China, India emerges as a key player. Companies like Apple are shifting production to India. This shift is due to...IndiaTimes |
SBI Report Urges India To Expand PLI Scheme As Trump Announces Reciprocal TariffsIndia is reportedly willing to significantly reduce tariffs on over USD 23 billion worth of American goods sold in India as part of the India-U.S. trade deal,...Zee News Also reported by •IndiaTimes |